ARENACCIO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 2.368
EU - Europa 1.053
AS - Asia 1.041
SA - Sud America 92
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 3
Totale 4.632
Nazione #
US - Stati Uniti d'America 2.334
SG - Singapore 430
RU - Federazione Russa 375
CN - Cina 351
GB - Regno Unito 174
SE - Svezia 124
DE - Germania 114
VN - Vietnam 85
FI - Finlandia 62
BR - Brasile 60
IT - Italia 57
HK - Hong Kong 40
IE - Irlanda 33
UA - Ucraina 32
JP - Giappone 26
BD - Bangladesh 25
CI - Costa d'Avorio 24
TR - Turchia 23
CA - Canada 19
DK - Danimarca 19
IN - India 18
AL - Albania 13
NL - Olanda 12
AR - Argentina 11
CO - Colombia 11
ID - Indonesia 10
AT - Austria 8
IQ - Iraq 6
MX - Messico 6
PL - Polonia 6
CZ - Repubblica Ceca 5
ES - Italia 5
PH - Filippine 5
ZA - Sudafrica 5
EC - Ecuador 4
KR - Corea 4
AU - Australia 3
DO - Repubblica Dominicana 3
FR - Francia 3
AZ - Azerbaigian 2
BE - Belgio 2
BH - Bahrain 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
JM - Giamaica 2
JO - Giordania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
VE - Venezuela 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
LT - Lituania 1
MA - Marocco 1
ME - Montenegro 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.601
Città #
Fairfield 286
Ashburn 251
Woodbridge 245
Singapore 209
Dallas 171
Chandler 146
Southend 138
Houston 132
Seattle 101
Wilmington 101
Cambridge 98
San Jose 96
Beijing 66
Ann Arbor 63
Boardman 56
Dearborn 49
Helsinki 41
Hong Kong 39
Nanjing 37
Shanghai 35
Jacksonville 34
Moscow 32
Dublin 31
Princeton 29
Dong Ket 26
Tokyo 26
Hefei 22
Los Angeles 22
Ho Chi Minh City 20
Redwood City 18
Shenyang 18
Izmir 17
The Dalles 17
Rome 16
Hanoi 15
Jinan 13
Munich 13
New York 13
Santa Clara 13
Hebei 12
San Diego 12
Changsha 11
Council Bluffs 10
Frankfurt am Main 10
Kunming 10
Plano 10
Columbus 9
Jiaxing 9
Montreal 9
Turku 9
Denver 8
London 8
Nanchang 8
São Paulo 8
Atlanta 7
Guangzhou 7
Jakarta 7
Milan 6
Tianjin 6
Brno 5
Böblingen 5
Haikou 5
Nuremberg 5
Orem 5
Pune 5
Warsaw 5
Ankara 4
Chennai 4
Chicago 4
Falls Church 4
Lanzhou 4
Mumbai 4
Seoul 4
Stockholm 4
Zhengzhou 4
Barranquilla 3
Boston 3
Bremen 3
Brooklyn 3
Cali 3
Flushing 3
Fort Worth 3
Hangzhou 3
Hải Dương 3
Johannesburg 3
Manchester 3
Phoenix 3
Rio de Janeiro 3
San Paolo di Civitate 3
Taizhou 3
Toronto 3
Tucson 3
Vienna 3
Yubileyny 3
Altamura 2
Amman 2
Auburn Hills 2
Baku 2
Biên Hòa 2
Bogotá 2
Totale 3.071
Nome #
Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism. 305
MiR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4+ T lymphocytes 266
The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIX(TM) Adjuvant 261
The ADAR1 editing enzyme is encapsidated into HIV-1 virions 253
HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation 251
HIV-1-infected cells transiently express lentiviral RNA shuttled by exosomes 245
Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1 224
The Contribution of Extracellular Nef to HIV-Induced Pathogenesis 218
Uncovering the role of defective HIV-1 in spreading viral infection 218
Surface-bound Tat inhibits antigen-specific CD8(+) T-cell activation in an integrin-dependent manner 215
Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1 210
HPV-E7 delivered by engineered exosomes elicits a protective CD8+ T cell-mediated immune response 206
HIV‐1 Nef Protein Affects Cytokine and Extracellular Vesicles Production in the GEN2.2 Plasmacytoid Dendritic Cell Line 198
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation 171
The intracellular delivery of anti-HPV16 E7 scFvs through engineered extracellular vesicles inhibits the proliferation of HPV-infected cells 170
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors 170
N-terminal fatty acids of NEFmut are required for the CD8+ t-cell immunogenicity of in vivo engineered extracellular vesicles 156
Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells 151
Exosomes in Therapy: Engineering, Pharmacokinetics and Future Applications 142
Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance 140
An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens 130
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion 129
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4+ T lymphocytes and reactivation of the HIV-1 reservoir 116
Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs 87
Totale 4.632
Categoria #
all - tutte 16.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022231 0 0 30 0 48 18 8 17 25 13 29 43
2022/2023405 41 92 16 43 37 70 2 24 36 3 22 19
2023/2024265 13 13 16 23 15 31 41 66 1 4 1 41
2024/2025674 6 7 56 6 6 30 288 135 36 30 43 31
2025/20261.324 116 230 96 139 162 63 185 18 116 135 48 16
2026/202734 21 13 0 0 0 0 0 0 0 0 0 0
Totale 4.632